Rochester, NY 7/10/2009 12:20:57 AM
WhisperfromWallStreet.com Afternoon Shakers - MRK - Merck, Portola in $470M deal for anticlotting drug
Merck & Co. Inc.,MRK
WhisperfromWallStreet.com Afternoon Shakers - MRK - Merck, Portola in $470M deal for anticlotting drug
---
Merck & Co. Inc.,MRK
Last Trade: 26.89
Day's Range: 26.58 - 27.90
52wk Range: 20.05 - 38.34
Volume: 16,872,137
Merck & Co. and Portola Pharmaceuticals Inc. said Thursday they have signed an exclusive deal to develop and market an experimental drug to prevent strokes in people with a dangerous irregular heart rhythm.
26.93 Down 1.11 (3.96%) 1:08PM ET
ABOUT THE COMPANY
Merck & Co., Inc. provides products for human and animal health in the United States and internationally. The company's Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents. Its products comprise Singulair, a leukotriene receptor antagonist for the treatment of asthma and allergic rhinitis; Cozaar, Hyzaar, Vasotec, and Vaseretic, the hypertension and/or heart failure products; Fosamax and Fosamax Plus D for treating osteoporosis; Januvia and Janumet for type 2 diabetes; Cosopt and Trusopt, the ophthalmological products; Zocor, an atherosclerosis product; Maxalt for acute migraine; Propecia to treat male pattern hair loss; Arcoxia to treat arthritis and pain; Proscar to treat symptomatic benign prostate enlargement; and Emend for the prevention of chemotherapy-induced and post-operative nausea and vomiting.
---
There are hundreds of stocks that rise and fall each day, our expertise is understanding which have the best opportunity for rapid growth. Our newsletter has sent out over 40 alerts this year with an average price gain of 80%. If you like to be alerted to the stocks that meets our criteria. Please join us for free to track our results.
You can sign up now for free stock alerts at WhisperfromWallStreet.com
---
Please read the COMPLETE DISCLAIMER posted on our website.
IMPORTANT NOTE: This is not a solicitation to buy or sell any securities. Neither WhisperfromWallStreet.com, nor any of its affiliates are registered investment advisors or a broker dealer. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
